ARCC

Ares Capital Corporation (ARCC) - Q1 2014 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2014. Ares Capital Corporation is a closed-end, non-diversified management investment company regulated as a Business Development Company (BDC) under the Investment Company Act of 1940. The Company is externally managed by Ares Capital Management LLC and invests primarily in first lien senior secured loans, second lien senior secured loans, and mezzanine debt, with a lesser focus on equity investments.

Key Financial Metrics

Material Changes vs. Prior Period

• Investment Income Growth: Total investment income increased by 23% year-over-year, driven primarily by a larger portfolio size (average amortized cost increased from $5.9 billion in Q1 2013 to $7.6 billion in Q1 2014) and higher capital structuring service fees ($20.9 million vs. $6.0 million).
• Expense Increase: Total expenses rose 32% to $122.0 million. This was due to higher interest and credit facility fees ($52.5 million vs. $39.4 million) resulting from increased debt levels, and higher management and incentive fees tied to the larger asset base and income generation.
• Unrealized Performance: The Company reported net unrealized losses of $7.4 million, a significant improvement from the $30.4 million net unrealized losses in Q1 2013. This improvement was driven by unrealized appreciation in several portfolio companies, partially offset by depreciation in others.
• Portfolio Composition: As of March 31, 2014, 83.3% of the portfolio was graded as "Grade 3" (neutral risk), while 12.7% was "Grade 4" (favorable risk). Only 0.7% of the portfolio was "Grade 1" (substantial risk).

Guidance, Outlook, and Risks

• Investment Activity: The Company made $852.1 million in new investment commitments during the quarter, funding $826.2 million. The weighted average yield of debt and other income-producing securities funded during the period was 9.3%.
• Liquidity: The Company maintains strong liquidity with $146.6 million in cash and approximately $2.1 billion available for additional borrowings under its credit facilities, subject to borrowing base and leverage restrictions.
• Dividends: The Company declared dividends of $0.43 per share for the quarter, totaling $128.1 million. The Company operates as a Regulated Investment Company (RIC) and intends to distribute at least 90% of its investment company taxable income to avoid corporate-level taxes.
• Legal Proceedings: The Company is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings LLC, alleging a "fraudulent transfer." The complaint seeks approximately $425 million in damages (with the Company's alleged share at $117 million) plus punitive damages. Management believes the claims are without merit and intends to defend vigorously.
• Market Risks: The Company is exposed to interest rate risk. As of March 31, 2014, 81% of investments bore variable interest rates. A 100 basis point increase in interest rates is estimated to increase annual net income by approximately $101.9 million (excluding incentive fee impacts), while a 100 basis point decrease would increase net income by $6.6 million due to interest rate floors on assets.

Key Facts for Investor Verification

• Debt Maturity Profile: Verify the weighted average maturity of outstanding debt (7.6 years) and the specific maturity dates of the Convertible Unsecured Notes (ranging from 2016 to 2019) and Unsecured Notes (ranging from 2018 to 2047).
• Senior Secured Loan Program (SSLP): Confirm the performance of the SSLP, a co-investment vehicle with GE. The Company holds $1.8 billion in SSLP certificates, which yielded 14.3% at fair value as of March 31, 2014.
• Non-Accrual Status: Monitor the 3.2% of total investments at amortized cost (1.9% at fair value) that were on non-accrual status as of March 31, 2014.
• Legal Exposure: Track the status of the DSI Renal Holdings litigation, as the potential liability ($117 million) is material relative to the Company's quarterly earnings.
• Valuation Methodology: Note that substantially all investments are valued at fair value determined in good faith by the Board of Directors, utilizing Level 3 inputs (unobservable data), which introduces estimation risk.